A further study reporting the prevalence of pANCA, ASCA IgA, ASCA IgG and anti-OmpC antibodies in 52 AS patients without IBD found the prevalence of all antibodies to be higher than in our study at 21%, 19%, 8% and 19% respectively [12]. Here, CD79A is linked to inflammatory bowel disease.